Primary sclerosing cholangitis - a comprehensive review.

[1]  T. Karlsen,et al.  Enhanced liver fibrosis test predicts transplant‐free survival in primary sclerosing cholangitis, a multi‐centre study , 2017, Liver international : official journal of the International Association for the Study of the Liver.

[2]  M. Manns,et al.  norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis. , 2017, Journal of hepatology.

[3]  M. Manns,et al.  Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis , 2017, Gut.

[4]  F. Gottrand,et al.  The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration , 2017, Hepatology.

[5]  T. Karlsen,et al.  Knockout of the primary sclerosing cholangitis‐risk gene Fut2 causes liver disease in mice , 2017, Hepatology.

[6]  T. Karlsen,et al.  Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link? , 2017, Gut.

[7]  F. Lund-Johansen,et al.  Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis. , 2017, Journal of hepatology.

[8]  M. Manns,et al.  Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. , 2017, Gastroenterology.

[9]  T. Karlsen,et al.  Genetics of primary sclerosing cholangitis and pathophysiological implications , 2017, Nature Reviews Gastroenterology &Hepatology.

[10]  C. Weston,et al.  Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner , 2017, Gut.

[11]  T. Karlsen,et al.  Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline , 2017, Endoscopy.

[12]  P. Schirmacher,et al.  Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study , 2017, Hepatology.

[13]  F. Bäckhed,et al.  Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota[S] , 2017, Journal of Lipid Research.

[14]  Mariza de Andrade,et al.  Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease , 2016, Nature Genetics.

[15]  Junfeng Wang,et al.  Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[16]  A. Quaas,et al.  Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis , 2016, PloS one.

[17]  T. Karlsen,et al.  Prevalence of Sclerosing Cholangitis Detected by Magnetic Resonance Cholangiography in Patients With Long-term Inflammatory Bowel Disease. , 2016, Gastroenterology.

[18]  T. Karlsen,et al.  Elevated interleukin‐8 in bile of patients with primary sclerosing cholangitis , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[19]  T. Karlsen,et al.  Anti-GP2 IgA autoantibodies are associated with poor survival and cholangiocarcinoma in primary sclerosing cholangitis , 2016, Gut.

[20]  T. Karlsen.  Primary sclerosing cholangitis: 50 years of a gut–liver relationship and still no love? , 2016, Gut.

[21]  G. Gores,et al.  Performance of magnetic resonance elastography in primary sclerosing cholangitis , 2016, Journal of gastroenterology and hepatology.

[22]  W. Lieb,et al.  Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis , 2016, Gut.

[23]  J. Raes,et al.  Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD , 2016, Gut.

[24]  D. Adams,et al.  Gut-liver immunity. , 2016, Journal of hepatology.

[25]  T. Karlsen,et al.  High‐throughput T‐cell receptor sequencing across chronic liver diseases reveals distinct disease‐associated repertoires , 2016, Hepatology.

[26]  Gemma L. Kay,et al.  The gut-adherent microbiota of PSC–IBD is distinct to that of IBD , 2016, Gut.

[27]  W. Stremmel,et al.  Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis , 2016, Medicine.

[28]  G. Gores,et al.  Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process , 2016, Hepatology.

[29]  Katherine R Meckel,et al.  The features of mucosa‐associated microbiota in primary sclerosing cholangitis , 2016, Alimentary pharmacology & therapeutics.

[30]  Tomohiro Watanabe,et al.  Pathogenicity of IgG in patients with IgG4-related disease , 2016, Gut.

[31]  F. Baas,et al.  Immunoglobulin G4+ B‐cell receptor clones distinguish immunoglobulin G 4‐related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies , 2016, Hepatology.

[32]  Søren Brunak,et al.  Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci , 2016, Nature Genetics.

[33]  G. Kaplan,et al.  Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis. , 2016, Journal of Crohn's & colitis.

[34]  M. Zali,et al.  Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran. , 2016, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[35]  A. Lohse,et al.  Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis , 2016, Gut.

[36]  T. Karlsen,et al.  The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls , 2016, Gut.

[37]  K. Boberg,et al.  Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. , 2016, Clinics in liver disease.

[38]  G. Hirschfield,et al.  Factors that Influence Health-Related Quality of Life in Patients with Primary Sclerosing Cholangitis , 2016, Digestive Diseases and Sciences.

[39]  M. Manns,et al.  Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  H. Vilstrup,et al.  Worldwide Incidence of Autoimmune Liver Disease , 2015, Digestive Diseases.

[41]  A. Burroughs,et al.  Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. , 2015, Journal of hepatology.

[42]  M. Leeflang,et al.  Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis. , 2015, Journal of hepatology.

[43]  T. Karlsen,et al.  Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis. , 2015, Journal of hepatology.

[44]  T. Karlsen,et al.  Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway , 2015, Transplantation direct.

[45]  H. Sintonen,et al.  Health‐related quality of life among patients with primary sclerosing cholangitis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[46]  T. Karlsen,et al.  Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.

[47]  T. Karlsen,et al.  Enhanced liver fibrosis score predicts transplant‐free survival in primary sclerosing cholangitis , 2015, Hepatology.

[48]  J. Raszeja-Wyszomirska,et al.  Prospective evaluation of PBC‐specific health‐related quality of life questionnaires in patients with primary sclerosing cholangitis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[49]  T. Karlsen,et al.  Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis. , 2015, Gastroenterology.

[50]  M. Trauner,et al.  New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. , 2015, Journal of hepatology.

[51]  A. Bartlett,et al.  Meta‐analysis of Duct‐to‐duct versus Roux‐en‐Y biliary reconstruction following liver transplantation for primary sclerosing cholangitis , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[52]  C. Langner,et al.  24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis , 2015, Journal of hepatology.

[53]  E. Zoetendal,et al.  The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II. , 2015, Journal of Crohn's & colitis.

[54]  A. Bergquist,et al.  Prospective evaluation of the clinical utility of single-operator peroral cholangioscopy in patients with primary sclerosing cholangitis , 2015, Endoscopy.

[55]  S. Barry,et al.  WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited. , 2015, The Journal of clinical investigation.

[56]  D. Thabut,et al.  Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles , 2015, Hepatology.

[57]  K. Okazaki,et al.  Clinical profiles of patients with primary sclerosing cholangitis in the elderly , 2015, Journal of hepato-biliary-pancreatic sciences.

[58]  R. Weersma,et al.  Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. , 2015, World journal of gastroenterology.

[59]  J. Bajaj,et al.  The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics , 2015, Acta pharmaceutica Sinica. B.

[60]  U. Navaneethan,et al.  ERCP-related adverse events in patients with primary sclerosing cholangitis. , 2015, Gastrointestinal endoscopy.

[61]  A. Bergquist,et al.  Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[62]  T. Karlsen,et al.  Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population , 2014, PloS one.

[63]  C. Lamb,et al.  Fatigue in primary sclerosing cholangitis is associated with sympathetic over‐activity and increased cardiac output , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[64]  A. Bergquist,et al.  Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET. , 2014, Journal of hepatology.

[65]  A. Burroughs,et al.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. , 2014, Gastroenterology.

[66]  W. Stremmel,et al.  Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis , 2014, Alimentary pharmacology & therapeutics.

[67]  T. Karlsen,et al.  Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[68]  B. French,et al.  Superior survival using living donors and donor‐recipient matching using a novel living donor risk index , 2014, Hepatology.

[69]  M. Manns,et al.  Low risk of hepatocellular carcinoma in patients with primary sclerosing cholangitis with cirrhosis. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[70]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[71]  U. Navaneethan,et al.  Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures: a systematic review and meta-analysis , 2014, Gastroenterology report.

[72]  A. Lohse,et al.  Transient elastography in primary sclerosing cholangitis-the value as a prognostic factor and limitations. , 2014, Gastroenterology.

[73]  Runping Liu,et al.  Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2 , 2014, Hepatology.

[74]  G. Reynolds,et al.  Loss of CD28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis. , 2014, Gastroenterology.

[75]  M. Manns,et al.  Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[76]  M. Manns,et al.  Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era , 2014, Langenbeck's Archives of Surgery.

[77]  U. Navaneethan,et al.  Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. , 2014, Gastrointestinal endoscopy.

[78]  U. Navaneethan,et al.  Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. , 2014, Gastrointestinal endoscopy.

[79]  A. Quaas,et al.  Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms. , 2014, Journal of hepatology.

[80]  F. Carrat,et al.  Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. , 2014, Gastroenterology.

[81]  R. Chapman,et al.  Serum Immunoglobulin G4 and Immunoglobulin G1 for Distinguishing Immunoglobulin G4-Associated Cholangitis From Primary Sclerosing Cholangitis , 2014, Hepatology.

[82]  A. Hoffman,et al.  Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2014, Endoscopy.

[83]  J. Furuse,et al.  Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[84]  K. Okazaki,et al.  Nationwide survey for primary sclerosing cholangitis and IgG4‐related sclerosing cholangitis in Japan , 2014, Journal of hepato-biliary-pancreatic sciences.

[85]  A. Amiot,et al.  European evidence based consensus for endoscopy in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.

[86]  P. Schirmacher,et al.  FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2013, Journal of hepatology.

[87]  F. Vleggaar,et al.  Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis , 2013, Hepatology.

[88]  R. Schwabe,et al.  Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology , 2013, Nature Communications.

[89]  J. Marin,et al.  Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development , 2013, Molecular Cancer Research.

[90]  J. Talwalkar,et al.  Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis , 2013, BioMed research international.

[91]  D. Adams,et al.  Mucosal immunity in liver autoimmunity: a comprehensive review. , 2013, Journal of autoimmunity.

[92]  A. Tanaka,et al.  Geoepidemiology of primary sclerosing cholangitis: a critical review. , 2013, Journal of autoimmunity.

[93]  S. Guthery,et al.  Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in utah children: Epidemiology and natural history , 2013, Hepatology.

[94]  C. Gieger,et al.  Genome‐wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4 , 2013, Hepatology.

[95]  J. Talwalkar,et al.  Inflammatory Bowel Disease after Liver Transplantation for Primary Sclerosing Cholangitis , 2013, The American Journal of Gastroenterology.

[96]  J. Neuberger,et al.  The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study. , 2013, Journal of hepatology.

[97]  S. Mallett,et al.  Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[98]  J. Boyer,et al.  Bile formation and secretion. , 2013, Comprehensive Physiology.

[99]  K. Boberg,et al.  Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[100]  H. Denk,et al.  Differential effects of norUDCA and UDCA in obstructive cholestasis in mice , 2013, Journal of hepatology.

[101]  Judy H. Cho,et al.  Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis , 2013, Nature Genetics.

[102]  F. Glenn,et al.  Primary sclerosing cholangitis. , 2013, Surgery, gynecology & obstetrics.

[103]  K. Reddy,et al.  Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[104]  F. Bäckhed,et al.  Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.

[105]  R. Chapman,et al.  Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis. , 2013, Journal of hepatology.

[106]  N. Heaton,et al.  The impact of inflammatory bowel disease post‐liver transplantation for primary sclerosing cholangitis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[107]  D. Kavanagh,et al.  CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver , 2012, Journal of hepatology.

[108]  M. Färkkilä,et al.  Risk factors for complications of ERCP in primary sclerosing cholangitis , 2012, Endoscopy.

[109]  J. Boyer,et al.  Molecular pathogenesis of cholestasis. , 2012, The New England journal of medicine.

[110]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[111]  V. Tremaroli,et al.  Functional interactions between the gut microbiota and host metabolism , 2012, Nature.

[112]  B. Petersen,et al.  Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience , 2012, Gut.

[113]  C. Gieger,et al.  Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. , 2012, Journal of hepatology.

[114]  M. Brown,et al.  Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis , 2012, Scandinavian Journal of Gastroenterology.

[115]  R. Chapman,et al.  A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease. , 2012, Journal of Crohn's & colitis.

[116]  K. Lindor,et al.  Likelihood of Malignancy in Gallbladder Polyps and Outcomes Following Cholecystectomy in Primary Sclerosing Cholangitis , 2012, The American Journal of Gastroenterology.

[117]  T. Karlsen,et al.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. , 2012, World journal of gastroenterology.

[118]  U. Beuers,et al.  What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree , 2012, Endoscopy.

[119]  C. Paulusma,et al.  A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes , 2012, Hepatology.

[120]  K. Boberg,et al.  Primary sclerosing cholangitis and malignancy. , 2011, Best practice & research. Clinical gastroenterology.

[121]  G. Gores,et al.  Cancer surveillance in patients with primary sclerosing cholangitis , 2011, Hepatology.

[122]  S. Halpern,et al.  Waitlist survival of patients with primary sclerosing cholangitis in the model for end‐stage liver disease era , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[123]  M. Trauner,et al.  Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice. , 2011, Gastroenterology.

[124]  N. Guañabens,et al.  Management of osteoporosis in liver disease. , 2011, Clinics and research in hepatology and gastroenterology.

[125]  T. Karlsen,et al.  Electrostatic Modifications of the Human Leukocyte Antigen-DR P9 Peptide-Binding Pocket and Susceptibility to Primary Sclerosing Cholangitis , 2011, Hepatology.

[126]  S. Halpern,et al.  Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis , 2011, Transplantation.

[127]  G. Kaplan,et al.  Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population‐based study , 2011, Liver international : official journal of the International Association for the Study of the Liver.

[128]  E. Björnsson,et al.  Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[129]  C. Hawkey,et al.  Meta‐analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease , 2011, Alimentary pharmacology & therapeutics.

[130]  M. Manns,et al.  Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. , 2011, Journal of hepatology.

[131]  C. Gluud,et al.  Bile acids for primary sclerosing cholangitis. , 2011, The Cochrane database of systematic reviews.

[132]  M. Manns,et al.  Multicentric evaluation of model for end‐stage liver disease‐based allocation and survival after liver transplantation in Germany – limitations of the ‘sickest first’‐concept , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[133]  D. Rockey,et al.  Identification and Functional Characterization of TMEM16A, a Ca2+-activated Cl− Channel Activated by Extracellular Nucleotides, in Biliary Epithelium* , 2010, The Journal of Biological Chemistry.

[134]  C. Wijmenga,et al.  Mutational Characterization of the Bile Acid Receptor TGR5 in Primary Sclerosing Cholangitis , 2010, PloS one.

[135]  M. Dave,et al.  Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography. , 2010, Radiology.

[136]  E. Björnsson,et al.  Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden , 2010, Hepatology.

[137]  M. Miyazaki,et al.  Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan , 2010, British Journal of Cancer.

[138]  G. Gores,et al.  Liver transplantation for cholangiocarcinoma , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[139]  D. Häussinger,et al.  The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes , 2010, Biological chemistry.

[140]  Y. Chrétien,et al.  Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study , 2010, European journal of gastroenterology & hepatology.

[141]  T. Karlsen,et al.  The utility of genome‐wide association studies in hepatology , 2010, Hepatology.

[142]  D. Cunningham,et al.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[143]  D. Gotthardt,et al.  Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment. , 2010, Gastrointestinal endoscopy.

[144]  C. Wijmenga,et al.  Genome-wide association analysis in primary sclerosing cholangitis. , 2010, Gastroenterology.

[145]  G. Gores,et al.  Diagnosis and management of primary sclerosing cholangitis , 2010, Hepatology.

[146]  J. Talwalkar,et al.  Precancerous Bile Duct Pathology in End-stage Primary Sclerosing Cholangitis, With and Without Cholangiocarcinoma , 2010, The American journal of surgical pathology.

[147]  T. Sauerbruch,et al.  p-ANCAs in autoimmune liver disorders recognise human β-tubulin isotype 5 and cross-react with microbial protein FtsZ , 2009, Gut.

[148]  D. Häussinger,et al.  The membrane‐bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders , 2009, Hepatology.

[149]  K. Lindor,et al.  High‐dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis , 2009, Hepatology.

[150]  D. Gotthardt,et al.  Influence of dominant bile duct stenoses and biliary infections on outcome in primary sclerosing cholangitis. , 2009, Journal of hepatology.

[151]  K. Zatloukal,et al.  Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice , 2009, Hepatology.

[152]  E. Parlak,et al.  Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis. , 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.

[153]  R. Odze,et al.  Pathologic Features of Ulcerative Colitis in Patients With Primary Sclerosing Cholangitis: A Case-control Study , 2009, The American journal of surgical pathology.

[154]  B. Petersen,et al.  Complications of Endoscopic Retrograde Cholangiopancreatography in Primary Sclerosing Cholangitis , 2009, The American Journal of Gastroenterology.

[155]  E. Björnsson.  Small-duct primary sclerosing cholangitis , 2009, Current gastroenterology reports.

[156]  K. Lindor,et al.  Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis , 2008, Hepatology.

[157]  A. Bergquist,et al.  Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[158]  G. Gores,et al.  Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment , 2008, Hepatology.

[159]  T. Karlsen,et al.  Autoantibodies in primary sclerosing cholangitis. , 2008, World journal of gastroenterology.

[160]  T. Karlsen,et al.  Gallbladder polyps in primary sclerosing cholangitis: not so benign , 2008, Current opinion in gastroenterology.

[161]  M. Kimmey,et al.  Complications after ERCP in patients with primary sclerosing cholangitis. , 2008, Gastrointestinal endoscopy.

[162]  A. Bergquist,et al.  Gallbladder disease in patients with primary sclerosing cholangitis. , 2008, Journal of hepatology.

[163]  M. Choti,et al.  Trends in Survival after Surgery for Cholangiocarcinoma: A 30-Year Population-Based SEER Database Analysis , 2007, Journal of Gastrointestinal Surgery.

[164]  N. Mitro,et al.  Insights in the regulation of cholesterol 7α‐hydroxylase gene reveal a target for modulating bile acid synthesis , 2007, Hepatology.

[165]  J. Talwalkar,et al.  Prevalence and Risk Factors for Gallbladder Neoplasia in Patients With Primary Sclerosing Cholangitis: Evidence for a Metaplasia-Dysplasia-Carcinoma Sequence , 2007, The American journal of surgical pathology.

[166]  G. Kaplan,et al.  The Burden of Large and Small Duct Primary Sclerosing Cholangitis in Adults and Children: A Population-Based Analysis , 2007, The American Journal of Gastroenterology.

[167]  C. Verslype,et al.  Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis , 2007, Digestive Diseases and Sciences.

[168]  F. Miller,et al.  Correlation Between Findings on MRCP and Gadolinium-Enhanced MR of the Liver and a Survival Model for Primary Sclerosing Cholangitis , 2007, Digestive Diseases and Sciences.

[169]  A. Bergquist,et al.  Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden , 2007, Scandinavian journal of gastroenterology.

[170]  A. Demetris.  Distinguishing between recurrent primary sclerosing cholangitis and chronic rejection , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[171]  K. Boberg,et al.  Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. , 2006, Journal of hepatology.

[172]  J. Neuberger,et al.  Life expectancy of adult liver allograft recipients in the UK , 2006, Gut.

[173]  T. Smyrk,et al.  Elevated Serum IgG4 Concentration in Patients with Primary Sclerosing Cholangitis , 2006, The American Journal of Gastroenterology.

[174]  U. Beuers.  Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[175]  M. Ziol,et al.  Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC , 2006, Hepatology.

[176]  K. Zatloukal,et al.  24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2006, Gastroenterology.

[177]  K. Chayama,et al.  Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage. , 2005, Free radical biology & medicine.

[178]  G. Gores,et al.  The Value of Serum CA 19-9 in Predicting Cholangiocarcinomas in Patients with Primary Sclerosing Cholangitis , 2005, Digestive Diseases and Sciences.

[179]  G. Gores,et al.  Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. , 2005, Gastroenterology.

[180]  M. Manns,et al.  Characterization, Outcome, and Prognosis in 273 Patients with Primary Sclerosing Cholangitis: A Single Center Study , 2005, The American Journal of Gastroenterology.

[181]  M. Harada,et al.  Biliary epithelial cells regulate autoreactive T cells: Implications for biliary‐specific diseases , 2005, Hepatology.

[182]  A. Cederborg,et al.  Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis , 2005, Scandinavian journal of gastroenterology.

[183]  A. Zinsmeister,et al.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis , 2004, Gut.

[184]  K. Das.  Immunopathogenesis of primary sclerosing cholangitis: possible role of a shared colonic and biliary epithelial antigen , 2004 .

[185]  Y. Nakanuma,et al.  Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[186]  B. Petersen,et al.  Cost‐minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis , 2004, Hepatology.

[187]  K. Lindor,et al.  Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.

[188]  E. Björnsson,et al.  Dominant Strictures in Patients with Primary Sclerosing Cholangitis , 2004, American Journal of Gastroenterology.

[189]  R. Chapman,et al.  Fatigue in patients with primary sclerosing cholangitis , 2004, Scandinavian journal of gastroenterology.

[190]  T. Therneau,et al.  Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. , 2003, Gastroenterology.

[191]  J. Horton,et al.  Gallstone disease and its complications. , 2003, Seminars in gastrointestinal disease.

[192]  R. Semelka,et al.  MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. , 2003, Radiology.

[193]  P. Heidenreich,et al.  Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. , 2002, Gastrointestinal endoscopy.

[194]  S. Sumitran-Holgersson,et al.  High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 , 2002, Gut.

[195]  W. Silverman,et al.  Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. , 2002, Gastrointestinal endoscopy.

[196]  G. Gores,et al.  In primary sclerosing cholangitis, gallbladder polyps are frequently malignant. , 2002 .

[197]  A. Bergquist,et al.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. , 2002, Journal of hepatology.

[198]  Thore Egeland,et al.  Time‐dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis , 2002, Hepatology.

[199]  P. Sauer,et al.  Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. , 2002, Journal of hepatology.

[200]  D. Adams,et al.  Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease , 2002, The Lancet.

[201]  K. Boberg,et al.  Cholangiocarcinoma in Primary Sclerosing Cholangitis: Risk Factors and Clinical Presentation , 2002, Scandinavian journal of gastroenterology.

[202]  R. Cameron,et al.  Accumulation of macrophages in primary sclerosing cholangitis. , 2001, Clinical biochemistry.

[203]  D. Adams,et al.  MAdCAM‐1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM‐1 in chronic inflammatory liver disease) , 2001, Hepatology.

[204]  D. Vergani,et al.  Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16‐year prospective study , 2001, Hepatology.

[205]  T M Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001, Hepatology.

[206]  O. Olerup,et al.  Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis , 2000, American Journal of Gastroenterology.

[207]  H. V. van Buuren,et al.  Prospective Risk Assessment of Endoscopic Retrograde Cholangiography in Patients with Primary Sclerosing Cholangitis , 2000, Endoscopy.

[208]  D. Alvaro,et al.  Regulation and deregulation of cholangiocyte proliferation. , 2000, Journal of hepatology.

[209]  G. Guyatt,et al.  Cholestatic liver diseases and health-related quality of life. , 2000 .

[210]  T. Therneau,et al.  Time course of histological progression in primary sclerosing cholangitis. , 1999 .

[211]  G. Tytgat,et al.  Four years experience with short term stenting in primary sclerosing cholangitis. , 1999 .

[212]  T. Therneau,et al.  Quality of life before and after liver transplantation for cholestatic liver disease , 1999, Hepatology.

[213]  S. Deventer,et al.  Immunohistochemical analysis of inflammation in primary sclerosing cholangitis. , 1998 .

[214]  H. Conjeevaram,et al.  Clinical course and management of inflammatory bowel disease after liver transplantation. , 1998, Transplantation.

[215]  T. Therneau,et al.  A revised natural history model for primary sclerosing cholangitis. , 1997, Mayo Clinic proceedings.

[216]  Randall G. Lee,et al.  A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. , 1997, The American journal of gastroenterology.

[217]  S. Viaggi,et al.  Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group. , 1996, European journal of gastroenterology & hepatology.

[218]  Å. Danielsson,et al.  Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. , 1996, Gut.

[219]  Å. Danielsson,et al.  Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis. , 1995, Journal of clinical pathology.

[220]  P. Borst,et al.  Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.

[221]  P. Grambsch,et al.  Primary sclerosing cholangitis: refinement and validation of survival models. , 1992, Gastroenterology.

[222]  W. Selby,et al.  Sclerosing cholangitis and biliary tract calculi--primary or secondary? , 1992, Gut.

[223]  T. Sauerbruch,et al.  Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial , 1992, Hepatology.

[224]  G. Lindberg,et al.  Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy? , 1992, Gastroenterology.

[225]  A. Czaja,et al.  Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. , 1992, Journal of hepatology.

[226]  B. Portmann,et al.  Natural history and prognostic variables in primary sclerosing cholangitis. , 1991, Gastroenterology.

[227]  G. Jeffrey,et al.  Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis. , 1991, Gut.

[228]  R. Sartor,et al.  Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. , 1990, Gastroenterology.

[229]  P. Grambsch,et al.  Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis , 1989, Hepatology.

[230]  A. Demetris,et al.  Intrahepatic bile duct strictures after human orthotopic liver transplantation , 1988, Transplant international : official journal of the European Society for Organ Transplantation.

[231]  R. Wiesner,et al.  Gallbladder disease in patients with primary sclerosing cholangitis. , 1988, AJR. American journal of roentgenology.

[232]  E. Schrumpf,et al.  Primary sclerosing cholangitis: a long-term follow-up study. , 1987, Scandinavian journal of gastroenterology.

[233]  J. Boyer,et al.  Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. , 1987, Gastroenterology.

[234]  R. Wiesner,et al.  Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. , 1985, Human pathology.

[235]  T. Whiteside,et al.  Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis , 1985, Hepatology.

[236]  J. Ludwig,et al.  Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts? , 1985, Annals of internal medicine.

[237]  N. LaRusso,et al.  Primary sclerosing cholangitis. , 1984, Journal of gastroenterology.

[238]  R. Chapman,et al.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. , 1980, Gut.

[239]  R. Wiesner,et al.  Clinicopathologic features of the syndrome of primary sclerosing cholangitis , 1980 .

[240]  A. Peña,et al.  Course and prognosis of Crohn's disease. , 1976, Gut.

[241]  J. S. van der Hoeven,et al.  Symbiosis of Streptococcus mutans and Veillonella alcalescens in mixed continuous cultures. , 1975, Archives of oral biology.

[242]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[243]  S. Sherlock,et al.  Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis. , 1967, Gut.

[244]  R. Loe,et al.  SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES. , 1965, American journal of surgery.

[245]  W. A. Dale,et al.  Primary sclerosing cholangitis; review and report of six cases. , 1958, A.M.A. archives of surgery.

[246]  A. Bergquist,et al.  Multicenter randomized trial comparing short-term stenting versus balloon dilatation for dominant strictures in primary sclerosing cholangitis , 2017 .

[247]  M. Manns,et al.  Efficacy and safety of simtuzumab for the treatment of primary sclerosing cholangitis: results of a phase 2b, dose-ranging, randomized, placebo-controlled trial , 2017 .

[248]  I. Pedrosa,et al.  Early Peribiliary Hyperenhancement on MRI in Patients with Primary Sclerosing Cholangitis: Significance and Association with the Mayo Risk Score , 2016, Abdominal Radiology.

[249]  A. Burroughs,et al.  EASL Clinical Practice Guidelines: Liver transplantation. , 2016, Journal of hepatology.

[250]  J. Drenth.  EASL Clinical Practice Guidelines: Autoimmune hepatitis. , 2015, Journal of hepatology.

[251]  Christian Gieger,et al.  Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci , 2011, Nature Genetics.

[252]  G. Kaplan,et al.  Incidence of primary sclerosing cholangitis: A systematic review and meta‐analysis , 2011, Hepatology.

[253]  F. Lammert,et al.  EASL Clinical Practice Guidelines: management of cholestatic liver diseases. , 2009, Journal of hepatology.

[254]  J. Bach,et al.  Infections and autoimmune diseases. , 2005, Journal of autoimmunity.

[255]  W. Silverman,et al.  Biliary tract calculi in primary sclerosing cholangitis. , 1995, The American journal of gastroenterology.

[256]  A. Parés,et al.  Epidemiology of primary sclerosing cholangitis in Spain , 1994 .

[257]  J. Lennard-jones,et al.  Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.

[258]  E. Schrumpf,et al.  Sclerosing cholangitis in ulcerative colitis. , 1980, Scandinavian journal of gastroenterology.

[259]  K. W. Warren,et al.  Primary sclerosing cholangitis. A study of forty-two cases. , 1966, American journal of surgery.